News

Top Innovations in Pediatric Dental Pain Management Guidelines

Top Innovations in Pediatric Dental Pain Management Guidelines

New Guidelines for Pediatric Dental Pain Management

A recent clinical practice guideline focused on pain management developed by Penn Dental Medicine is gaining recognition as a leading resource in pediatric dental care. Specifically crafted through the insights of the Center for Integrative Global Oral Health (CIGOH), this guideline has been highlighted as one of the most notable articles by The Journal of the American Dental Association (JADA).

Collaborative Efforts in Guideline Development

This essential guideline, aimed at successfully managing acute dental pain in children, is the result of a robust collaboration involving CIGOH, the American Dental Association Science and Research Institute (ADASRI), and the University of Pittsburgh School of Dental Medicine. The initiative was co-led by Dr. Alonso Carrasco-Labra, who serves as an Associate Professor and Director at the Cochrane Oral Health Collaborating Center, alongside epidemiologist Olivia Urquhart.

Recommended Treatments for Dental Pain

As endorsed by the American Dental Association, the guideline advocates for the use of acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen as effective first-line treatments for addressing short-term dental pain in children under the age of 12. Research indicates that when taken as prescribed, these medications can significantly alleviate discomfort from procedures such as tooth extractions or during instances of toothaches, particularly when immediate dental care is unavailable.

Safety Protocols for Medication Use

The guidelines emphasize that when administered under the guidance of a qualified dentist or healthcare provider, the associated risks for children taking acetaminophen or NSAIDs safely are notably low. This reflects a crucial step forward in pediatric dental medicine, ensuring both efficacy and safety in pain relief approaches.

Alignment with FDA Recommendations

The recommendations laid out in the guideline correspond with previous guidance issued by the U.S. Food and Drug Administration (FDA) in 2017, specifically discouraging the use of codeine and tramadol in a pediatric setting. The FDA further supported the development of pain management resources by awarding a $1.5 million grant to the University of Pittsburgh and ADASRI with the aim of developing clinical practice guidelines that encompass various age groups.

Comprehensive Research Collaborations

To generate this comprehensive guideline for pediatric dentistry, a range of researchers and methodologists from various reputable institutions including CIGOH and McMaster University pooled their expertise. The result of their efforts is not only a guideline focused on children but also an additional guideline for adolescents and adults published shortly thereafter.

Accessing the Guidelines

Both of these vital guidelines are readily accessible to dental care providers and can be found on the ADA website, highlighting the commitment to improving pain management practices in dentistry for all ages. These documents stand as indispensable resources that will benefit practitioners and their young patients alike.

Contact Information for Further Details

For additional details, practitioners or interested parties can reach out to Beth Adams, who is available for inquiries and further insights on the guidelines.

Frequently Asked Questions

What is the focus of the new pediatric dental guidelines?

The guidelines primarily focus on effectively managing acute dental pain in children using approved medications like acetaminophen and NSAIDs.

Who contributed to the development of these guidelines?

The guidelines were developed collaboratively by Penn Dental Medicine's CIGOH, ADASRI, and the University of Pittsburgh School of Dental Medicine, among others.

What medications are recommended for managing dental pain in children?

Acetaminophen and NSAIDs such as ibuprofen are recommended as first-line treatments for short-term pain management in children under 12.

How does the guideline ensure safety for child patients?

The guideline indicates that when used as directed by healthcare providers, the risk of harm associated with the recommended medications is very low.

Where can dental professionals find these guidelines?

Dental professionals can access the guidelines on the ADA's official website, which provides resources on pain management strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading

Top 5 Most Recently Viewed Articles

Daimon Robotics Raises RMB 100 Million for Robotics Innovation

Updated Category News Views 200

Daimon Robotics Secures Significant Funding for Future Innovations Daimon Robotics has recently secured over RMB 100 million in an Angel++ funding round. This influx of capital, primarily led by China Merchants Venture and supported by other investors, signifies a pivotal moment in the advancement of robotics technology. The company’s focus on enhancing tactile sensing...

Continue Reading
WeRide's Groundbreaking Achievement in Autonomous Driving

Updated Category News Views 275

WeRide Achieves Level-4 Driverless Permit in France WeRide (Nasdaq: WRD), a leader in autonomous driving technology, has reached an important milestone by securing a Level-4 driverless public road testing and operating permit in France. Collaborating with beti, a prominent player in the French autonomous mobility network, this achievement positions WeRide as the only...

Continue Reading
Anticipating Earnings: Insights into First Citizens BancShares

Updated Category News Views 148

Upcoming Earnings Announcement for First Citizens BancShares First Citizens BancShares (NASDAQ: FCNCA) is set to unveil its quarterly earnings report soon, and investors are eager to see what the figures reveal. This announcement is keenly anticipated, with analysts forecasting an earnings per share (EPS) of $41.50, a critical metric for those tracking the bank's...

Continue Reading
Is the 'Sell America 2.0' Trend Resurfacing in the Market?

Updated Category News Views 81

Market Update: Examining Leadership Shifts As global yields rise, US megacaps face pressure as investors revisit the 'Sell America' strategy. Notably, the S&P 500 has recently broken important technical levels, with noticeable fatigue in tech, media, and telecom leadership. On the other hand, diversification appears to be paying off, as small caps, foreign equities, and...

Continue Reading
KFT Marketplace Launches Exciting Food Hall in Chester

Updated Category News Views 355

KFT Marketplace Launches in Chester KFT Marketplace has officially opened its doors, marking an exciting new chapter for Kung Fu Tea, the leading bubble tea brand in the country. This innovative food hall concept brings together different culinary experiences under one roof, providing a unique dining destination for food lovers. Amazing Culinary Experiences At KFT...

Continue Reading